Orion Biotechnology
PrivateLast Round
Series A
Extension
Mar 15, 2023
Total Funding Raised
$27.02M
Company Overview
Orion Biotechnology is a biotechnology company that develops next-generation therapeutics targeting G Protein-Coupled Receptors (GPCRs) for cancer, obesity, and metabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orion Biotechnology Comparables
Compare Orion Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Superluminal Medicines | 84% | |
| Ambrosia Biosciences Inc. | 83% | |
| Confo Therapeutics | 81% |
Orion Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 15, 2023 | ||||
| Grant | Nov 4, 2021 | ||||
| Series A | Jun 17, 2021 | ||||
| SAFE | Oct 9, 2020 | ||||
| Grant | Jul 30, 2020 | ||||
Grant | Apr 22, 2019 |
Key People
Founding team and executive leadership
Orion Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | SAFE, Series A Extension, Series A |
| National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2020
Received funding from National Research Council of Canada Industrial Research Assistance Program.
Orion Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orion Biotechnology's valuation, stock price, and market status.
Is Orion Biotechnology a public or private company?
Orion Biotechnology is a private company.
What is the current stock price of Orion Biotechnology?
Orion Biotechnology is a private company with no public stock price. No recent secondary market data is available.
How much is Orion Biotechnology worth (valuation)?
Valuation information for Orion Biotechnology is not publicly available.
Can I buy Orion Biotechnology stock?
Orion Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Orion Biotechnology's last funding round?
Orion Biotechnology's most recent funding round was Series A Extension on March 15, 2023.
Who are the main investors in Orion Biotechnology?
Key investors in Orion Biotechnology include Keiretsu Forum.
Will Orion Biotechnology IPO soon?
No public IPO plans have been announced for Orion Biotechnology.
How can I track Orion Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orion Biotechnology's secondary market activity and sign up for updates.